Aptorum Group Ltd Class A (APM)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 16.07M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 4.47
52W Low
$ 0.46
Dividend Yield
0.00%
Beta
-0.28
Technicals
50-Day MA
1.4416
200-Day MA
1.1171
52 Week High
4.47
52 Week Low
0.46
About APM
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and .
Employees
1
Headquarters
London, United Kingdom
CEO
Mr. Chung Yuen Huen
Latest News
APM Terminals Pecem sees 48% growth on direct Asia service - Seatrade Maritime News
10 hours ago • Google News